First Phantom-Based Quantitative Assessment of Scandium-44 Using a Commercial PET Device
Scandium (Sc) is a promising candidate for theranostic applications due to the existence of radioisotopes suitable for both imaging and therapy. A “proof-of-concept” study regarding first-in-human use of 44Sc for imaging metastatic neuroendocrine tumors was reported recently, however, quantitative a...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-07-01
|
| Series: | Frontiers in Physics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fphy.2020.00241/full |